<ѻý>GLP-1s: The Medications Redefining Diabetes and Obesity Treatmentѻý> Experts tackle access, equity, and the blockbuster drugs reshaping healthcare Dec 04, 2024 video
<ѻý>ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Upѻý> News and commentary from the endocrinology world Dec 03, 2024
<ѻý>Drug Prices Negotiated by Medicare Still Higher Than Other Countries'ѻý> All drugs except one remained more expensive in the U.S. Dec 02, 2024
<ѻý>Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndromeѻý> News and commentary from the endocrinology world Nov 26, 2024
<ѻý>Many Drinkers Cut Back After Starting Obesity Meds, Study Findsѻý> In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
<ѻý>CGM Uptake Very Low for Vulnerable Diabetes Populationsѻý> But how to achieve equitable use remains "complicated," says expert Nov 22, 2024
<ѻý>GLP-1 Use Prior to Surgery: Analyzing the Updated Guidanceѻý> Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
<ѻý>Metformin Use Linked to Fewer Asthma Attacksѻý> Addition of GLP-1 drugs led to an even greater reduction Nov 19, 2024
<ѻý>75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?ѻý> News and commentary from the endocrinology world Nov 19, 2024
<ѻý>Over 50% of U.S. Adults Qualify for Ozempic, Wegovyѻý> Most are eligible for weight management indication Nov 18, 2024
<ѻý>Extended Dosing Intervals Possible With Aflibercept in Diabetic Macular Edemaѻý> In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose Nov 18, 2024 video
<ѻý>Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefitѻý> SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
<ѻý>Multiple Chronic Conditions and Death; Diabetes Treatment for Goutѻý> Also in TTHealthWatch: frailty as a predictor of dementia Nov 16, 2024 podcast
<ѻý>GLP-1 Drugs Could Help People With Alcohol Use Disorderѻý> Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
<ѻý>16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surgeѻý> News and commentary from the endocrinology world Nov 12, 2024
<ѻý>Who Needs a Defibrillator After MI? FDA Recs on Inferior Vena Cava Filtersѻý> Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes Nov 09, 2024 podcast
<ѻý>FDA Adds New Warning to GLP-1 Drugsѻý> Labels now caution about pulmonary aspiration risk Nov 08, 2024
<ѻý>Slow Start for AI-Assisted Screening for Diabetic Retinopathy Despite Promiseѻý> Ophthalmologists hope expanded use will lead to more evaluations in primary clinics Nov 08, 2024
<ѻý>Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancerѻý> Health news and commentary gathered by ѻý staff Nov 08, 2024
<ѻý>Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Yearsѻý> Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
<ѻý>Early-Life Sugar Restriction Reduced Diabetes, Hypertension Riskѻý> Diagnoses were also delayed the longer sugar was restricted Nov 06, 2024
<ѻý>Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy?ѻý> Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
<ѻý>CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Downѻý> News and commentary from the endocrinology world Nov 05, 2024
<ѻý>ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patientsѻý> New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
<ѻý>Metformin and Congenital Abnormalities; Deprescribing in Patients With Dementiaѻý> Also in TTHealthWatch: best medications for opioid use disorder Oct 26, 2024 podcast
<ѻý>GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroidsѻý> GLP-1 receptor agonists may have better protective benefits versus metformin, insulin Oct 24, 2024
<ѻý>Ozempic Linked With Lower Risk of Alzheimer's Diagnosisѻý> Large observational study suggests further research is warranted Oct 24, 2024
<ѻý>Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patientsѻý> Findings leave researcher "concerned" Oct 23, 2024
<ѻý>Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kidsѻý> News and commentary from the endocrinology world Oct 22, 2024
<ѻý>No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonistsѻý> Conundrum of holding meds continues following conflicting reports of aspiration events Oct 22, 2024
<ѻý>Serious Battery Issue Prompts Medtronic Insulin Pump Recallѻý> Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases Oct 18, 2024
<ѻý>Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancerѻý> News and commentary from the endocrinology world Oct 15, 2024
<ѻý>CHEST Roundup: Diabetes in RA Patients Ups Risk of Interstitial Lung Diseaseѻý> Plus: nalbuphine for IPF cough and AI for reducing lung allograft discards Oct 14, 2024
<ѻý>Type 2 Diabetes Diagnoses Emerge in Teens Months After COVIDѻý> Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
<ѻý>Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementiaѻý> News and commentary from the endocrinology world Oct 08, 2024
<ѻý>What Skin Says About Healthѻý> Knowing what to look for can mean the difference between life and death Oct 03, 2024
<ѻý>Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1Dѻý> News and commentary from the endocrinology world Oct 01, 2024
<ѻý>Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopyѻý> Bowel preparation protocols appeared protective in small study Oct 01, 2024
<ѻý>Happy People, Happy Hearts? Ultra-Processed Foods and Diabetes Riskѻý> Also in TTHealthWatch: AACR report on cancer Sep 28, 2024 podcast